Cortney Young
Family · Bossier City, LANPI 1093086274
Payments from drug & device makers
Across 112 payments — averaging $15.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$237
- AbbVie$234
- Amgen$188
- GSK$149
- Novo Nordisk$123
- AstraZeneca$110
- plus $648 from 20 others
What the payments were for
- Food & beverage$1,688100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 16 | $237 |
| AbbVie | 26 | $234 |
| Amgen | 11 | $188 |
| GSK | 8 | $149 |
| Novo Nordisk | 8 | $123 |
| AstraZeneca | 6 | $110 |
| Pfizer | 7 | $109 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $92 |
| Novartis | 5 | $91 |
| Acadia Pharmaceuticals Inc | 2 | $39 |
| Abiomed | 1 | $33 |
| Biohaven Pharmaceuticals, Inc. | 2 | $27 |
| Kowa Pharmaceuticals America, Inc. | 2 | $26 |
| Phathom Pharmaceuticals, Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Ironwood Pharmaceuticals, Inc | 1 | $19 |
| Tris Pharma Inc | 1 | $18 |
| Eisai Inc. | 1 | $18 |
| Exact Sciences | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Shield Therapeutics Inc | 1 | $16 |
| Adlon Therapeutics L.p. | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $13 |
| Merck | 1 | $13 |
How this compares
$1,688 in reported general payments places this provider in the 70th percentile of 3,610 family providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 40 | $43,441 |
| MounjaroTirzepatide | 13 | $13,419 |
| EliquisApixaban | 14 | $9,604 |
| FarxigaDapagliflozin Propanediol | 15 | $7,257 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 14 | $1,151 |
| Levothyroxine Sodium | 105 | $849 |
| SynthroidLevothyroxine Sodium | 15 | $809 |
| Tolterodine Tartrate ErTolterodine Tartrate | 11 | $795 |
| Omeprazole | 45 | $779 |
| Atorvastatin Calcium | 93 | $713 |
| Metoprolol Succinate | 30 | $673 |
| Pantoprazole Sodium | 58 | $657 |
| Potassium Chloride | 37 | $632 |
| Rosuvastatin Calcium | 46 | $617 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 23 | $586 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $123 | $43,44140 claims |
| Lilly USA, LLCMounjaro | $237 | $13,41913 claims |
| PfizerEliquis | $109 | $9,60414 claims |
| AstraZenecaFarxiga | $110 | $7,25715 claims |
| AbbVieSynthroid | $234 | $80915 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,610 family providers in Louisiana.
Other family in Bossier City
- Rebecca EzellSlidell$268K
- Erin PierceNew Orleans$261K
- Tavell KindallNew Orleans$194K
- Ashlea HillRuston$169K
- Brittany MillerVille Platte$158K
- Ryanne ClarkeGretna$123K
- Elidia DewittBaton Rouge$108K
- Rebekah GarrardLafayette$105K
- Tiffany RoeShreveport$97K
- Ghenet GhebretatiosBaton Rouge$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.